Concepedia

Prahlad V. Raninga

PV

19

Publications

915

Citations

17

H-Index

2010

Active since

Affiliations

QIMR Berghofer Medical Research Institute(Current)

Griffith University

The University of Queensland

Translational Research Institute

UNSW Sydney

Prahlad V. Raninga is an author at QIMR Berghofer Medical Research Institute specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2010–2023

19

Publications

19

<scp>CEP</scp> 55 is a determinant of cell fate during perturbed mitosis in breast cancer

Murugan Kalimutho, Debottam Sinha, Jessie Jeffery et al. · EMBO Molecular Medicine · 2018 · 105 citations · Full text

Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer

Prahlad V. Raninga, Andy Chao Hsuan Lee, Debottam Sinha et al. · International Journal of Cancer · 2019 · 86 citations · Full text

Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

Prahlad V. Raninga, Giovanna Di Trapani, Slavica Vučković et al. · Oncotarget · 2015 · 85 citations · Full text

RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC

Seong‐Jin Kim, Jin‐Sung Ju, Myoung Hee Kang et al. · Theranostics · 2020 · 73 citations · Full text

The Multifaceted Roles of DJ-1 as an Antioxidant

Prahlad V. Raninga, Giovanna Di Trapani, Kathryn F. Tonissen · Advances in experimental medicine and biology · 2017 · 66 citations

, , +4

Rows per page

1–5 of 19